Nomizo, Takashi, Haruka Yamamoto, Tsunetaka Murayama, Hiroko Fukata, Yasukiyo Nakamura, Mami Sonomura, Aika Okuno, Naoki Kanda, Chihiro Watanabe, and Hideo Kita. 2022. “Immune-Related Adverse Events Caused by Combined Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Lung Cancer”. Trends in Immunotherapy 6 (1). https://doi.org/10.24294/ti.v6.i1.1386.